Check out our most popular compounded medications! Get Started
Flurbiprofen 50 mg Slow Release Capsules, formulated with Methocel E4M, provide a gradual release of the active ingredient for sustained therapeutic effects. This controlled-release mechanism reduces dosing frequency and improves patient compliance.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
We are delighted to introduce Flurbiprofen 50 mg Slow Release Capsules, a powerful medication designed to alleviate a variety of conditions. Flurbiprofen is a non-steroidal anti-inflammatory drug (NSAID) that works by inhibiting the production of certain chemicals in the body that cause inflammation and pain. It is frequently prescribed for a range of conditions, including arthritis, bursitis, tendinitis, and menstrual cramps.
Our Flurbiprofen 50 mg Slow Release Capsules are uniquely formulated with Methocel E4M, a type of controlled-release polymer. This advanced formulation is designed to gradually release the encapsulated medication over an extended period of time. The slow-release mechanism provides sustained therapeutic effects, reduces the frequency of dosing, and enhances patient compliance, especially for medications that necessitate a controlled and prolonged release profile.
The slow and steady release of the medication over a longer duration allows Flurbiprofen 50 mg Slow Release Capsules to provide more consistent relief of symptoms.
It is essential to take the medication as directed and maintain regular follow-ups with your healthcare provider to ensure optimal results. If you have any questions about Flurbiprofen 50 mg Slow Release Capsules or any other medication, please do not hesitate to contact us. Our team of experienced compounding pharmacists is always ready to assist you.
At Bayview Pharmacy, we are committed to providing high-quality compounded medications tailored to meet individual patient needs. Our Flurbiprofen 50 mg Slow Release Capsules are a testament to our dedication to patient care and innovative pharmaceutical solutions. We look forward to serving your medication needs and helping you achieve optimal health outcomes.
Flurbiprofen 50 mg Slow Release Capsules are formulated with Methocel E4M, a type of controlled-release polymer. This formulation is designed to gradually release the encapsulated medication over an extended period of time, providing sustained therapeutic effects, reduced dosing frequency, and improved patient compliance. However, it's important to note that this medication may interact with a wide range of other medications, supplements, or herbs you may be taking.
It's crucial to inform your healthcare provider about all other medications you use, including vitamins and herbs. This includes medications used to treat a variety of conditions such as depression, anxiety, high blood pressure, heart disease, diabetes, infections, cancer, HIV/AIDS, immune system disorders, seizures, neurological conditions, asthma, allergies, respiratory conditions, stomach or intestinal conditions, arthritis, gout, musculoskeletal conditions, blood clotting disorders, thyroid conditions, hormonal conditions, eye conditions, skin conditions, urinary tract infections, liver or kidney conditions, high cholesterol or triglycerides, Parkinson's disease, Alzheimer's disease, and other mental health conditions.
Discontinuing any medications without first consulting your healthcare provider is not recommended. If you have any questions or concerns about the potential interactions of Flurbiprofen 50 mg Slow Release Capsules with other medications, supplements, or herbs, please do not hesitate to seek further information from your healthcare provider.
Flurbiprofen 50 mg Slow Release Capsules are a specialized formulation of a nonsteroidal anti-inflammatory drug (NSAID) used to alleviate pain and inflammation associated with various conditions such as rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis. This unique formulation incorporates Methocel E4M, a type of controlled-release polymer, which is designed to gradually release the encapsulated medication over an extended period of time. This slow release mechanism offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for medications requiring a controlled and prolonged release profile.
The slow release formulation of Flurbiprofen works by inhibiting the production of certain chemicals in the body that cause inflammation and pain. This action helps to reduce the swelling, stiffness, and pain associated with these conditions. The slow release formulation of flurbiprofen allows for a more sustained release of the drug over a longer period of time, providing more consistent relief of symptoms.
Flurbiprofen 50 mg Slow Release Capsules should be taken as directed by your healthcare provider. The capsules should be swallowed whole with a full glass of water. It is crucial not to crush, chew, or break the capsules. Consistency is key when taking this medication, so it is recommended to take it at the same time each day to ensure consistent levels of the drug in the body.
Before starting Flurbiprofen 50 mg Slow Release Capsules, it is important to have a discussion with your healthcare provider. This medication may not be suitable for everyone and may cause side effects. Always consult with your healthcare provider if you have any questions or concerns about taking this medication.
Flurbiprofen 50 mg Slow Release Capsules is a medication formulated with Methocel E4M, a type of controlled-release polymer. This formulation is designed to release the encapsulated medication gradually over an extended period of time, offering sustained therapeutic effects.
The slow release formulation offers sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile.
Methocel E4M is a type of controlled-release polymer used in the formulation of Flurbiprofen 50 mg Slow Release Capsules. It is designed to release the encapsulated medication gradually over an extended period of time.
Due to its slow release formulation, the frequency of dosing is reduced. However, the exact dosing schedule should be determined by your healthcare provider based on your specific condition and response to therapy.
Flurbiprofen is a nonsteroidal anti-inflammatory drug (NSAID) that works by reducing hormones that cause inflammation and pain in the body. The slow release formulation ensures these effects are sustained over a longer period of time.
Yes, the slow release formulation of Flurbiprofen 50 mg Capsules is designed to improve patient compliance by reducing the frequency of dosing and providing sustained therapeutic effects.
Flurbiprofen 50 mg Slow Release Capsules should only be taken under the supervision of a healthcare provider. It may not be suitable for individuals with certain health conditions or those who are taking certain medications. Always consult your healthcare provider before starting any new medication.
As with any medication, Flurbiprofen 50 mg Slow Release Capsules can cause side effects. Common side effects may include upset stomach, nausea, heartburn, diarrhea, constipation, bloating, gas, dizziness, headache, or drowsiness. If any of these effects persist or worsen, notify your healthcare provider promptly.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Take your next dose at the regular time. Do not double the dose to catch up.
Store Flurbiprofen 50 mg Slow Release Capsules at room temperature, away from light and moisture. Do not store in the bathroom. Keep all medications away from children and pets.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
